You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
Engineering of KR-12 derived from human host defence peptide LL-37 into stable, selective and potent antimicrobial drug lead
- In: Short Communications A1 on Monday, 22 May 2017, 13:30-15:00
- At: Stockholm (Sweden) (2017)
- Type: Presentation
- By: MUHAMMAD, Taj (Uppsala University, Medicinal Chemsitry, Uppsala, Sweden)
- Co-author(s): Taj Muhammad : Medicinal Chemsitry, Uppsala University, Uppsala, Sweden
Sunithi Gunasekera: Medicinal Chemsitry, Uppsala University, Uppsala, Sweden
Adam A. Strömstedt: Medicinal Chemsitry, Uppsala University, Uppsala, Sweden
Ulf Goransson: Medicinal Chemsitry, Uppsala University, Uppsala, Sweden - Abstract:
Backgrounds
The human cathelicidin LL-37 is a multifunctional host defence molecule that mediates various host responses including antimicrobial action, chemotaxis, epithelial cell activation, angiogenesis, epithelial wound repair and activation of chemokine secretion. However, LL-37 encounters the generic problems common to most linear counter.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026